13. Consider the information concerning the costs and QALYS for various treatments for heart disease that is presented in the table below: Treatment Cost per TreatmentQALYs Gained A B C 100 300 400 600 800 2 8 8 12 15 E F Which treatment alternative(s) is (are) not economically rational (NER) because it is (they are) dominated? а. В O b. B & C О с.С O d. D

46. Consider the information concerning the costs and QALYS for various treatments for cancer that is presented in the table below. Which of the treatments is/are dominated? Cost per QALYS Gained Cancer Treatment Treatment 200 400 10 500 12 K 600 6. 700 14 Oa.G. O b. H. OCK OdL Oe None of the above

3. Consider the adverse selection model of health insurance. ● (a) Why is the marginal cost curve negatively sloped?

If surgeons really have the ability to increase thedemand for surgeries, which kinds of surgerieswill be most affected? Can you think of a way todetermine which surgeries are unnecessary? Provide several examples from your own readings orexperience.

explain whether or not you feel Ford did anything morally wrong in weighing the economics of the Pinto manufacturing versus consumer deaths.  Also, do you think it was a legitimate defense for Ford to state that their cars met or exceeded the safety standards set by the US government?

Note:- Do not provide handwritten solution. Maintain accuracy and quality in your answer. Take care of plagiarism. Answer completely. You will get up vote for sure.

Suppose that one course of treatment costs $500,000. If given to patient A, it will increase life expectancy by one month; for patient B, by two months; for patient C, by three months; and for patient D, by four months. The marginal cost per additional year of life for the patient most likely to benefit is and the marginal cost per additional year of life for the patient least likely to benefit is O $500,000; $2 million $1.5 million; $6 million $200,000; $500,000 O $2 million; $500,000 $6 million; $1.5 million

Suppose a US medical board is using marginal analysis to determine the optimal screening frequency for a specific disease. Below is the approximate number of early cases detected as you expand testing to a broarder population. Suppose further that each early detection case is considered to have a benefit of $50,000 and the cost of screening one person is $20,000. Number of people Total Number of screened in a Early Detection given a year Cases 1,000 500 2,000 1000 3,000 1400 4,000 1700 5,000 1900 The marginal benefit to screening 2 thousand people is, and 3 thousand people is 500 early detection cases ($25,000,000); 400 cases ($20,000,000) 1000 early detection cases ($50,000,000); 1400 ($70,000,000) early cases O 1400 ($70,000,000) early cases; 1000 early detection cases ($50,000,000) 400 cases ($20,000,000); 500 early detection cases ($25,000,000) P